Medicine traceability means being able to find, for each batch, where it came from, where it was stored, which ward received it and, for high-risk products, which patient. It rests on a simple rule: record the batch number and expiry date at every step, from supplier to patient. That is what allows a fast response to a batch recall or a suspected falsified product.
Key takeaways
- Traceability follows the batch at every step: purchase, receipt, storage, issue, administration.
- The batch number and expiry date are the two pieces of information never to lose.
- Buying from licensed suppliers is the first protection against falsified products.
- In a recall, well-kept traceability quickly identifies the stock and wards concerned.
- The level of detail, ward or patient, is decided product by product according to risk.
Why medicine traceability is a priority
National regulators can order the recall of a defective batch: in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC); in Ghana, the Food and Drugs Authority (FDA). WHO also issues alerts on substandard and falsified medical products. Without traceability, a facility knows neither whether it holds the batch concerned nor to whom it was issued.
Example: the regulator announces the recall of a batch of infusion fluid. A clinic in Enugu that records batches on receipt quickly knows whether it received that batch, how much is left and which wards received it. Without that record, staff must search every shelf and every ward cupboard.
The five steps of the traceability chain
| Step | Information to record | Reference document |
|---|---|---|
| Purchase | Supplier, product, quantity ordered | Purchase order |
| Receipt | Batch number, expiry date, quantity received, condition | Delivery note, invoice |
| Storage | Location, transfers between stores | Stock card |
| Issue to a ward | Batch, quantity, receiving ward, date | Issue voucher |
| Dispensing or administration | Batch, patient, prescription | Prescription, patient record |
Each step depends on the previous one. Example: if the batch is not recorded on receipt, it cannot be traced later in a ward or in a patient’s record.
Securing supply at the source
Traceability starts with the choice of suppliers. Buy from wholesalers and distributors licensed by the national authorities, and keep a supplier file with their up-to-date licences.
Checking every delivery
- Compare the delivery with the purchase order: product, strength, form, quantity.
- Record the batch number and expiry date of each product.
- Inspect the packaging: integrity, labelling, leaflet, anything unusual.
- Quarantine any doubtful product and alert the pharmacist.
- Record the receipt into stock the same day.
Example: on receipt, a storekeeper in Kumasi notices that one box carries a label different from the other boxes of the same batch. He quarantines it, and the pharmacist queries the supplier before any use.
Following the batch to the ward and the patient
Inside the facility, the batch follows the product. Every issue voucher to a ward states the batch issued, applying the “first expired, first out” rule. Example: the operating theatre receives infusion fluids from a given batch; in a recall, the pharmacy knows at once that the theatre’s reserve must be checked.
How far to go: ward or patient?
Tracing every batch to the patient requires more data entry. A pragmatic approach is to start with high-risk products: costly injectables, controlled drugs, implantable devices. Example: a surgical clinic records the batch of each implanted device in the patient’s record, and stops at ward level for routine consumables.
Expiry date monitoring, detailed in our article on stock-outs and expiries in the hospital pharmacy, relies on the same batch data.
Handling a batch recall: the procedure
- Receive the alert (regulator, supplier or WHO) and appoint a person in charge.
- Search for the batch in stock receipts.
- Immediately block remaining stock, in the pharmacy and in the wards.
- Identify the wards and, where possible, the patients who received the batch.
- Inform management and the doctors concerned, who decide what to do for patients.
- Return or destroy the products as instructed, and keep a written report.
The medical side, meaning informing or following up patients, belongs to doctors. Management’s role is to give them a reliable list quickly.
Also report any quality defect to the national pharmacovigilance system. These practices strengthen quality of care and traceability across the facility.
Medicine traceability and MediFlow
MediFlow’s stock room already covers the first part of this chain: receiving products, stock movements, batches, expiry dates, reorder alerts and stock-out forecasts, up to issue from the stock room.
The rest of the circuit, from the pharmacy to the patient, will be covered by the pharmacy and smart medical follow-up modules, in development. During a demo, the MediFlow team reviews your current workflows with you.
Frequently asked questions
What information should be recorded to trace a medicine?
At a minimum: the product, the supplier, the batch number, the expiry date, the quantity and the date of each movement. On issue, add the receiving ward and, for high-risk products, the patient. Without a batch number, no search is possible in a recall.
How should we respond to a batch recall alert?
Appoint a person in charge, search for the batch in your stock receipts, immediately block remaining stock and identify the wards or patients concerned. Doctors then decide what to do for patients. Keep a written report of every action taken.
How can we protect ourselves from falsified medicines?
Buy only from suppliers licensed by the national authorities and check every delivery: packaging, labelling, batch, expiry date. Quarantine any doubtful product and report it to the regulator. Avoid buying outside official channels, even during a stock-out.
Want to see how MediFlow fits your facility? Request a free demo.
